Top-Rated StocksTop-RatedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free EVH Stock Alerts $23.07 -0.24 (-1.03%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$22.91▼$23.4650-Day Range$23.06▼$33.8652-Week Range$22.91▼$35.00Volume2.22 million shsAverage Volume1.30 million shsMarket Capitalization$2.68 billionP/E RatioN/ADividend YieldN/APrice Target$42.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Evolent Health alerts: Email Address Evolent Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.92 Rating ScoreUpside/Downside82.1% Upside$42.00 Price TargetShort InterestBearish9.68% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.05Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth58.62%From $0.87 to $1.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.91 out of 5 starsComputer And Technology Sector317th out of 590 stocksManagement Services Industry5th out of 5 stocks 4.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.68% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 12, which indicates bearish sentiment.Change versus previous monthShort interest in Evolent Health has recently decreased by 1.14%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 2.3 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Evolent Health this week, compared to 3 articles on an average week.Search Interest7 people have searched for EVH on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 58.62% in the coming year, from $0.87 to $1.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -18.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -18.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesMay 15 at 1:54 AM | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by AnalystsMay 14, 2024 | americanbankingnews.comEvolent Health (NYSE:EVH) PT Lowered to $34.00 at JMP SecuritiesMay 12, 2024 | americanbankingnews.comEvolent Health (NYSE:EVH) Price Target Cut to $41.00May 11, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Evolent Health (EVH)May 11, 2024 | finance.yahoo.comEvolent Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 11, 2024 | americanbankingnews.comEvolent Health (NYSE:EVH) Shares Gap Down on Analyst DowngradeMay 10, 2024 | finance.yahoo.comEvolent Health Inc (EVH) Surpasses Revenue Estimates Despite Net Loss in Q1 2024May 10, 2024 | finance.yahoo.comEvolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finanznachrichten.deEvolent Health, Inc.: Evolent Announces First Quarter 2024 ResultsMay 9, 2024 | sfgate.comEvolent Health: Q1 Earnings SnapshotMay 9, 2024 | prnewswire.comEvolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.May 9, 2024 | prnewswire.comEvolent Announces First Quarter 2024 ResultsApril 23, 2024 | msn.comCitigroup Initiates Coverage of Evolent Health (EVH) with Buy RecommendationApril 18, 2024 | investing.comEvolent Health stock maintains price target with Overweight ratingApril 18, 2024 | prnewswire.comEvolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024April 15, 2024 | finance.yahoo.comEvolent Health, Inc. (EVH)April 7, 2024 | finance.yahoo.comRecent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 yearsMarch 16, 2024 | finance.yahoo.comEVH Apr 2024 27.500 putMarch 15, 2024 | markets.businessinsider.comNavigating 4 Analyst Ratings For Evolent HealthMarch 1, 2024 | msn.comOppenheimer Initiates Coverage of Evolent Health (EVH) with Outperform RecommendationFebruary 27, 2024 | finance.yahoo.comWall Street Analysts Predict a 35.7% Upside in Evolent Health (EVH): Here's What You Should KnowFebruary 26, 2024 | finance.yahoo.comHere's What Analysts Are Forecasting For Evolent Health, Inc. (NYSE:EVH) After Its Annual ResultsFebruary 24, 2024 | finance.yahoo.comEvolent Health Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 23, 2024 | markets.businessinsider.comThese Analysts Revise Their Forecasts On Evolent Health After Upbeat ResultsFebruary 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 4 Ratings For Evolent HealthSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today5/18/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryN/A Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$42.00 High Stock Price Target$52.00 Low Stock Price Target$34.00 Potential Upside/Downside+82.1%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E Ratio26.52 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-5.07% Pretax Margin-6.02% Return on Equity6.90% Return on Assets2.79% Debt Debt-to-Equity Ratio0.57 Current Ratio1.02 Quick Ratio1.01 Sales & Book Value Annual Sales$2.18 billion Price / Sales1.23 Cash Flow$1.77 per share Price / Cash Flow13.06 Book Value$9.02 per share Price / Book2.56Miscellaneous Outstanding Shares116,213,000Free Float111,621,000Market Cap$2.68 billion OptionableOptionable Beta1.57 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 45)Co-Founder, CEO & Director Comp: $2MMr. Dan McCarthy (Age 39)CEO of New Century Health & President Comp: $1.4MMr. John Paul Johnson (Age 40)Chief Financial Officer Comp: $1.13MMr. Aammaad Shams (Age 40)Chief Accounting Officer Comp: $341.78kMr. Robert CruzChief Technology OfficerMs. Jessica WhiteChief Information OfficerMr. Seth R. FrankVice President of Investor RelationsMs. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerMr. Scott PritchardPresident of Performance SuiteMore ExecutivesKey CompetitorsRumbleNASDAQ:RUMIntappNASDAQ:INTACogent CommunicationsNASDAQ:CCOIInterDigitalNASDAQ:IDCCKulicke and Soffa IndustriesNASDAQ:KLICView All CompetitorsInsiders & InstitutionsRA Capital Management L.P.Bought 3,187,000 shares on 5/17/2024Ownership: 4.969%Comerica BankSold 1,144 shares on 5/17/2024Ownership: 0.056%Walleye Trading LLCSold 11,900 shares on 5/17/2024Ownership: 0.000%California State Teachers Retirement SystemSold 9,618 shares on 5/16/2024Ownership: 0.090%Bayesian Capital Management LPBought 17,035 shares on 5/16/2024Ownership: 0.015%View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price target for 2024? 12 equities research analysts have issued 12-month target prices for Evolent Health's shares. Their EVH share price targets range from $34.00 to $52.00. On average, they anticipate the company's share price to reach $42.00 in the next twelve months. This suggests a possible upside of 82.1% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2024? Evolent Health's stock was trading at $33.03 at the beginning of 2024. Since then, EVH stock has decreased by 30.2% and is now trading at $23.07. View the best growth stocks for 2024 here. Are investors shorting Evolent Health? Evolent Health saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 11,380,000 shares, an increase of 7.3% from the March 31st total of 10,610,000 shares. Based on an average daily volume of 934,800 shares, the short-interest ratio is currently 12.2 days. View Evolent Health's Short Interest. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024. View our EVH earnings forecast. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) issued its quarterly earnings results on Thursday, February, 22nd. The technology company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.02 by $0.13. The technology company earned $556.06 million during the quarter, compared to analyst estimates of $541.87 million. Evolent Health had a positive trailing twelve-month return on equity of 6.90% and a negative net margin of 5.07%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), Harbor Small Cap Explorer ETF (QWST), Jpmorgan Healthcare Leaders ETF (JDOC) and iShares U.S. Healthcare Providers ETF (IHF) and What guidance has Evolent Health issued on next quarter's earnings? Evolent Health updated its second quarter 2024 earnings guidance on Thursday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $625.0 million-$645.0 million, compared to the consensus revenue estimate of $606.6 million. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.46%), RA Capital Management L.P. (4.97%), William Blair Investment Management LLC (3.22%), Hood River Capital Management LLC (1.91%), Bellevue Group AG (1.28%) and Silvercrest Asset Management Group LLC (0.64%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:EVH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBill Clinton Backing Biden Replacement???The Freeport SocietyI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.